Testing for genetic risk factors may improve myeloma treatments by identifying those at risk for more aggressive disease. This study, published in the Journal of Clinicial Oncology and led by researchers in London, including our own Myeloma Institute Director, Dr. Gareth Morgan, is the first to link genetic mutations in myeloma cells to the chances of surviving the disease.
Genetic Mutation Analysis May Improve Treatment in Multiple Myeloma
- Haematological cancer: Where are we now with the treatment of multiple myeloma?
- Altmetric: 5More detail Article | OPEN Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
- Trails and Tribulations
- Subaru and Leukemia & Lymphoma Society Blanket Myeloma Institute with Love
- From the Director